{"status": "OK", "response": {"docs": [{"score": 7.836789e-05, "web_url": "https://www.nytimes.com/2016/03/04/business/daily-stock-market-activity.html", "section_name": "Business Day"}, {"score": 7.836689e-05, "web_url": "https://www.nytimes.com/2016/02/27/business/dealbook/ubs-faces-money-laundering-and-fraud-inquiry-in-belgium.html", "section_name": "Business Day"}, {"score": 7.832783e-05, "web_url": "https://www.nytimes.com/2016/03/06/business/retirementspecial/marketers-take-second-look-at-over-50-consumers.html", "section_name": "Business Day"}, {"score": 7.832272e-05, "web_url": "https://www.nytimes.com/reuters/2016/02/29/business/29reuters-china-economy-pmi-caixin.html", "section_name": "Business Day"}, {"score": 7.829054e-05, "web_url": "https://www.nytimes.com/2016/03/01/business/dealbook/valeant-chief-returns-to-a-difficult-to-do-list.html", "section_name": "Business Day"}, {"score": 7.825035e-05, "web_url": "https://www.nytimes.com/2016/03/01/business/for-hotels-bedbugs-are-bad-enough-and-social-media-adds-to-irritation.html", "section_name": "Business Day"}, {"score": 7.82425e-05, "web_url": "https://www.nytimes.com/2016/03/01/business/daily-stock-market-activity.html", "section_name": "Business Day"}, {"score": 7.821945e-05, "web_url": "https://www.nytimes.com/2016/03/01/business/valeant-pharmaceuticals-is-under-sec-investigation.html", "section_name": "Business Day"}, {"score": 7.81678e-05, "web_url": "https://www.nytimes.com/2016/02/24/business/dealbook/new-energy-investment-vehicle-raises-450-million-in-ipo.html", "section_name": "Business Day"}, {"score": 7.808312e-05, "web_url": "https://www.nytimes.com/2016/02/27/business/economy/feds-transparency-may-give-investors-false-confidence-economists-say.html", "section_name": "Business Day"}], "meta": {"hits": 4475, "time": 131, "offset": 630}}, "copyright": "Copyright (c) 2018 The New York Times Company. All Rights Reserved."}